Andorra vs Israel: Previously treated cases tested for RR-/MDR-TB
Andorra
100.0%
in 2014
Israel
100.0%
in 2024
Andorra rank
1st
Israel rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Andorra
- Israel
How they compare
Andorra currently reports 100.0% against 100.0% in Israel, a difference of 0.0%.
The two have swapped places 1 time across 5 shared years of data; in 2006 it was Israel ahead.
Andorra ranks 1st and Israel ranks 1st of 180 countries.
Across the 2 decades both report, Andorra averaged higher in 1 and Israel in 1.
Head to head by decade
| Decade | Andorra | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.7% | 61.3% | 44.7% | Israel |
| 2010s | 100.0% | 78.5% | 21.5% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Andorra or Israel?
- Andorra, at 100.0% against 100.0% in Israel as of 2014.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Andorra and Israel?
- 0.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Israel?
- 5 years are reported by both, from 2006 to 2014.
- How do Andorra and Israel rank globally for previously treated cases tested for rr-/mdr-tb?
- Andorra ranks 1st and Israel ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.